高MAL2表达预测三阴性乳腺癌女性的生存时间较短

Jędrzej Borowczak1, Marek Zdrenka1, Weronika Socha2

  • 1Department of Tumor Pathology and Pathomorphology, Oncology Centre, Prof. Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland.

概括

高MAL2表达表明三阴性乳腺癌 (TNBC) 患者的预后不佳. 这一发现在多个患者队列中是一致的,突出显示MAL2是TNBC的潜在预后生物标志物.